Proto Labs Reports Record Revenue and Net Income for the Fourth Quarter and Full Year 2017 - Proto Labs (NYSE:PRLB)

Record Quarterly Revenue of $94.2 million, an increase of 30.2% over 2016

Record Full Year 2017 Revenue of $344.5 million, an increase of 15.6% over 2016

Proto Labs, Inc. (NYSE:PRLB), a leading online and technology-enabled, quick-turn, on-demand manufacturer, today announced financial results for the fourth quarter and full year ended December 31, 2017.

Fourth Quarter 2017 Highlights include:

Additional Fourth Quarter 2017 Highlights include:

Full Year 2017 Highlights include:

Additional 2017 Highlights include:

Non-GAAP Financial Measures

The company has included non-GAAP operating margin, adjusted for stock-based compensation expense, amortization expense, acquisition costs, impairment on assets and facilities-related charges (collectively, "non-GAAP operating margin"), in this press release to provide investors with additional information regarding the company's financial results.

Conference Call

About Proto Labs, Inc.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180208005245/en/

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

Record Quarterly Revenue of $94.2 million, an increase of 30.2% over 2016

Record Full Year 2017 Revenue of $344.5 million, an increase of 15.6% over 2016

Fourth Quarter 2017 Highlights include:

Revenue for the fourth quarter of 2017 was a record $94.2 million, representing a 30.2 percent increase over revenue of $72.4 million in the fourth quarter of 2016.
Fourth quarter revenue included $3.6 million revenue contribution from RAPID Manufacturing ("RAPID"), the New Hampshire company acquired in the fourth quarter of 2017. Excluding the revenue from RAPID and the impact of discontinued services, revenue increased 26.1 percent compared with the prior year's fourth quarter. Adjusting for the positive impact on revenue from foreign currency exchange rates, revenue growth was 28.3 percent. See "Non-GAAP Financial Measures" below.
The number of unique product developers and engineers served totaled 16,985 in the fourth quarter of 2017, an increase of 20.9 percent over the fourth quarter of 2016.
Net income for the fourth quarter of 2017 was a record $14.3 million, or $0.53 per diluted share.
The Tax Cuts and Jobs Act of 2017 (the "Tax Act") resulted in a current period net benefit of $1.9 million, with a benefit from the revaluation of deferred tax liabilities partially offset by deemed repatriation of foreign earnings.
Non-GAAP net income, excluding the after-tax expense of stock compensation, amortization of intangibles, acquisition costs, impairment on assets, unrealized foreign currency gains and the net benefit in the current period resulting from the Tax Act was $15.7 million, or $0.58 per diluted share. See "Non-GAAP Financial Measures" below.

Additional Fourth Quarter 2017 Highlights include:

Gross margin was 56.2 percent of revenue for the fourth quarter of 2017, compared with 55.7 percent for the fourth quarter of 2016.
GAAP operating margin was 19.9 percent of revenue during the fourth quarter of 2017, compared to 20.5 percent for the fourth quarter of 2016.
Non-GAAP operating margin was 25.1 percent of revenue during the fourth quarter of 2017, compared to 23.1 percent for the fourth quarter of 2016. See "Non-GAAP Financial Measures" below.
The Company generated $22.7 million in cash from operations during the fourth quarter of 2017.
Cash and investments balance was $131.2 million at December 31, 2017.

"Proto Labs continues to demonstrate its ability to provide solutions to our customers to help them accelerate product development, reduce risk and optimize supply chains by delivering custom parts at unprecedented speeds. The fourth quarter was a strong ending to a great year," said Vicki Holt, President and Chief Executive Officer. "During the quarter, we delivered double-digit revenue growth in each of our services and in each of our regions on a constant currency basis. We were especially pleased with the growth of revenue from our CNC business, up 37.6 percent organically. We continue to enhance our technology to further expand the services that we can provide to our customers."

Full Year 2017 Highlights include:

Revenue increased 15.6 percent to $344.5 million compared with $298.1 million in 2016. Adjusting for the $3.6 million revenue contribution from RAPID, and the impact of discontinued services, adjusted revenue totaled $340.4 million, an increase of 16.1 percent compared to 2016. See "Non-GAAP Financial Measures" below.
Net income for 2017 increased to $51.8 million, or $1.93 per diluted share compared with $42.7 million, or $1.61 per diluted share in 2016.
Non-GAAP net income, excluding the after-tax expense of stock compensation, amortization of intangibles, impairment of assets, acquisition costs, unrealized foreign currency gains, legal settlement and the net benefit in the current period resulting from the Tax Act was $57.4 million, or $2.14 per diluted share. See "Non-GAAP Financial Measures" below.
Cash generated from operations during the year totaled $81.7 million.

Additional 2017 Highlights include:

Completion of our acquisition of RAPID manufacturing in the fourth quarter.
Expansion of our service offerings with the launch of insert molding and on demand manufacturing in injection molding and the addition of multi-jet fusion and Polyjet to our 3D printing service.
Served over 37,000 product developers during the year, an increase of 18.5 percent.
Established a share repurchase program.

"Our accomplishments in 2017, including the acquisition of RAPID and the continued expansion of our services, will allow us to provide more of a total solution to our customers. These accomplishments have positioned us well for continued, sustainable growth in both revenue and earnings. Our customer focus will continue in 2018 as we continue to evolve our sales approach to develop deeper customer relationships, further advance each of our four service offerings, and increase the scale of our operations, with an initial focus on integrating the RAPID acquisition." concluded Holt.

Non-GAAP Financial Measures

The company has included non-GAAP adjusted revenue growth that excludes the impact of changes in foreign currency exchange rates and non-GAAP adjusted revenue growth that excludes the impact of acquired and discontinued businesses in this press release to provide investors with additional information regarding the company's financial results. Management believes these metrics are useful in evaluating the underlying business trends and ongoing operating performance of the company.

The company has included non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, impairment on assets, facilities-related charges, acquisition costs, unrealized foreign currency activity, legal settlement, provisional charges related to the tax effect of deemed repatriation of foreign earnings, and revaluation of net deferred tax assets associated with the Tax Act (collectively, "non-GAAP net income"), in this press release to provide investors with additional information regarding the company's financial results.

The company has provided below reconciliations of GAAP to non-GAAP net income, operating margin and revenues, the most directly comparable measures calculated and presented in accordance with GAAP. These non-GAAP measures are used by the company's management and board of directors to understand and evaluate operating performance and trends and provide useful measures for period-to-period comparisons of the company's business. Accordingly, the company believes that these non-GAAP measures provide useful information to investors and others in understanding and evaluating operating results in the same manner as our management and board of directors.

Conference Call

The company has scheduled a conference call to discuss its fourth quarter and full year 2017 financial results today, February 8, 2018 at 8:30 a.m. ET. To access the call in the U.S. please dial 877-709-8150 or outside the U.S. dial 201-689-8354 at least five minutes prior to the 8:30 a.m. start time. No participant code is required. A simultaneous webcast of the call will be available via the investor relations section of the Proto Labs website and the following link: https://edge.media-server.com/m6/p/jrmdwby8. A replay will be available for 14 days following the call on the investor relations section of Proto Labs' website.

About Proto Labs, Inc.

Proto Labs is the world's fastest digital manufacturing source for rapid prototyping and on-demand production. The technology-enabled company produces custom parts and assemblies in as fast as 1 day with automated 3D printing, CNC machining, sheet metal fabrication, and injection molding processes. Its digital approach to manufacturing enables accelerated time to market, reduces development and production costs, and minimizes risk throughout the product life cycle. Visit protolabs.com for more information.


Proto Labs, Inc.
Condensed Consolidated Balance Sheets
(In thousands)


	December 31,		December 31,
	2017 ¹		2016
	(Unaudited)
Assets
Current assets
Cash and cash equivalents	$	36,707	$	68,795
Short-term marketable securities		57,424		39,477
Accounts receivable, net		51,503		34,060
Inventory		11,271		9,310
Income taxes receivable		461		445
Other current assets		6,267		5,697
Total current assets		163,633		157,784

Property and equipment, net		166,662		139,474
Long-term marketable securities		37,034		84,479
Goodwill		129,752		28,916
Other intangible assets, net		17,614		2,655
Other long-term assets		2,672		933
Total assets	$	517,367	$	414,241

Liabilities and shareholders' equity
Current liabilities
Accounts payable	$	15,876	$	11,322
Accrued compensation		12,100		7,670
Accrued liabilities and other		8,408		4,435
Short-term debt obligations		5,000		-
Income taxes payable		1,000		-
Total current liabilities		42,384		23,427

Long-term income taxes payable		2,181		-
Long-term deferred tax liabilities		6,966		7,003
Other long-term liabilities		4,621		3,978

Shareholders' equity		461,215		379,833
Total liabilities and shareholders' equity	$	517,367	$	414,241


¹The unaudited condensed consolidated balance sheet at December 31, 2017 reflects the preliminary allocation of RAPID's purchase price to identifiable tangible and intangible net assets acquired and the excess purchase price to goodwill. A final determination of the fair value of the assets acquired and liabilities assumed may differ materially from the preliminary estimates.


Proto Labs, Inc.
Condensed Consolidated Statements of Operations
(In thousands, except share and per share amounts)
(Unaudited)

	Three Months Ended				Year Ended
	December 31,				December 31,
	2017		2016		2017		2016
Revenue
Injection Molding	$	50,245	$	41,598	$	194,432	$	175,974
CNC Machining		30,421		20,897		103,739		81,407
3D Printing		11,268		9,788		43,329		37,847
Sheet Metal		1,767		-		1,767		-
Other		477		70		1,223		2,827
Total revenue		94,178		72,353		344,490		298,055

Cost of revenue		41,290		32,041		150,648		131,118
Gross profit		52,888		40,312		193,842		166,937

Operating expenses
Marketing and sales		15,393		11,949		56,856		46,131
Research and development		5,776		5,278		23,560		22,388
General and administrative		12,944		8,254		41,200		36,651
Total operating expenses		34,113		25,481		121,616		105,170
Income from operations		18,775		14,831		72,226		61,767
Other income, net		430		112		2,209		2,454
Income before income taxes		19,205		14,943		74,435		64,221
Provision for income taxes		4,933		5,571		22,657		21,514
Net income	$	14,272	$	9,372	$	51,778	$	42,707

Net income per share:
Basic	$	0.53	$	0.35	$	1.94	$	1.62
Diluted	$	0.53	$	0.35	$	1.93	$	1.61

Shares used to compute net income per share:
Basic		26,705,909		26,457,302		26,647,610		26,365,173
Diluted		27,009,017		26,609,929		26,845,071		26,564,639


Proto Labs, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)

	Year Ended
	December 31,
	2017			2016
Operating activities
Net income	$	51,778		$	42,707
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		18,474			17,485
Stock-based compensation expense		8,558			6,775
Deferred taxes		90			2,780
Amortization of held-to-maturity securities		1,063			1,173
Loss on impairment of assets		513			455
Other		(153	)		(1,541	)
Changes in operating assets and liabilities		1,425			7,665
Net cash provided by operating activities		81,748			77,499

Investing activities
Purchases of property and equipment		(32,635	)		(33,616	)
Cash used for acquisitions, net of cash acquired		(110,533	)		-
Purchases of marketable securities		(20,037	)		(89,315	)
Proceeds from maturities of marketable securities		47,972			62,176
Purchases of other assets and investments		(8,742	)		-
Net cash used in investing activities		(123,975	)		(60,755	)

Financing activities
Proceeds from issuance of debt		5,000			-
Acquisition-related contingent consideration		-			(400	)
Proceeds from exercises of stock options and other		8,602			5,715
Repurchases of common stock		(4,410	)		-
Net cash provided by financing activities		9,192			5,315
Effect of exchange rate changes on cash and cash equivalents		947			(917	)
Net (decrease) increase in cash and cash equivalents		(32,088	)		21,142
Cash and cash equivalents, beginning of period		68,795			47,653
Cash and cash equivalents, end of period	$	36,707		$	68,795


Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Net Income per Share
(In thousands, except share and per share amounts)
(Unaudited)

	Three Months Ended						Year Ended
	December 31,						December 31,
	2017			2016			2017			2016
Non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, impairment on assets, acquisition costs, unrealized (gain) loss on foreign currency, charges related to the exit of facilities and legal settlement
GAAP net income	$	14,272		$	9,372		$	51,778		$	42,707
Add back:
Stock-based compensation expense		2,400			1,515			8,558			6,775
Amortization expense		107			163			501			683
Impairment on assets		513			-			513			455
Acquisition costs		1,875			-			1,875			-
Unrealized (gain) loss on foreign currency		(102	)		217			(185	)		(1,243	)
Facilities-related charges		-			222			-			1,373
Legal settlement		-			-			(417	)		-
Total adjustments ¹		4,793			2,117			10,845			8,043
Provisional charges related to the tax effect of deemed repatriation of foreign earnings		2,400			-			2,400			-
Revaluation of net deferred tax assets and liabilities		(4,262	)		-			(4,262	)		-
Income tax benefits on adjustments ²		(1,520	)		(646	)		(3,344	)		(3,139	)
Non-GAAP net income	$	15,683		$	10,843		$	57,417		$	47,611


Non-GAAP net income per share:
Basic	$	0.59		$	0.41		$	2.16		$	1.81
Diluted	$	0.58		$	0.41		$	2.14		$	1.79

Shares used to compute non-GAAP net income per share:
Basic		26,705,909			26,457,302			26,647,610			26,365,173
Diluted		27,009,017			26,609,929			26,845,071			26,564,639

¹Stock-based compensation expense, amortization expense, impairment on assets, acquisition costs, unrealized (gain) loss on foreign currency, facilities-related charges and legal settlement were included in the following GAAP consolidated statement of operations categories:

	Three Months Ended						Year Ended
	December 31,						December 31,
	2017			2016			2017			2016
Cost of revenue	$	273		$	318		$	970		$	1,318
Marketing and sales		405			234			1,429			974
Research and development		295			312			1,091			1,396
General and administrative		3,922			1,036			7,957			5,598
Other income, net		(102	)		217			(602	)		(1,243	)
Total adjustments	$	4,793		$	2,117		$	10,845		$	8,043

²For the three months and year ended December 31, 2017 and 2016, income tax effects were calculated using the effective tax rate for the relevant jurisdictions. Our non-GAAP tax rates differ from our GAAP tax rates due primarily to the mix of activity incurred in domestic and foreign tax jurisdictions.


Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Operating Margin
(In thousands)
(Unaudited)

	Three Months Ended						Year Ended
	December 31,						December 31,
	2017			2016			2017			2016
Revenue	$	94,178		$	72,353		$	344,490		$	298,055
Income from operations		18,775			14,831			72,226			61,767
GAAP operating margin		19.9	%		20.5	%		21.0	%		20.7	%
Add back:
Stock-based compensation expense		2,400			1,515			8,558			6,775
Amortization expense		107			163			501			683
Acquisition Costs		1,875			-			1,875			-
Impairment on assets		513			-			513			455
Facilities-related charges		-			222			-			1,373
Total adjustments		4,895			1,900			11,447			9,286
Non-GAAP income from operations adjusted for stock-based compensation expense, amortization expense, acquisition costs, impairment on assets and facilities-related charges	$	23,670		$	16,731		$	83,673		$	71,053
Non-GAAP operating margin		25.1	%		23.1	%		24.3	%		23.8	%


Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth
(In thousands)
(Unaudited)

								Three Months Ended
	Three Months Ended December 31, 2017							December 31,2016		%			% Change Constant
	GAAP		Adjustments¹			Non-GAAP		GAAP		Change²			Currencies³
Revenues
United States	$	72,067	$	-		$	72,067	$	54,566		32.1	%		32.1	%
Europe		18,930		(1,427	)		17,503		14,847		27.5	%		17.9	%
Japan		3,181		106			3,287		2,940		8.2	%		11.8	%
Total Revenue	$	94,178	$	(1,321	)	$	92,857	$	72,353		30.2	%		28.3	%


								Year Ended
	Year Ended December 31, 2017							December 31, 2016		%			% Change Constant
	GAAP		Adjustments¹			Non-GAAP		GAAP		Change²			Currencies³
Revenues
United States	$	263,086	$	-		$	263,086	$	223,930		17.5	%		17.5	%
Europe		70,154		(282	)		69,872		63,365		10.7	%		10.3	%
Japan		11,250		361			11,611		10,760		4.6	%		7.9	%
Total Revenue	$	344,490	$	79		$	344,569	$	298,055		15.6	%		15.6	%

¹ Revenue growth for the three month and year ended periods ended December 31, 2017 has been recalculated using 2016 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
² This column presents the percentage change from GAAP revenue growth for the three month and year ended periods ended December 31, 2016 to GAAP revenue growth for the three month and year ended periods ended December 31, 2017.
³ This column presents the percentage change from GAAP revenue growth for the three month and year ended periods ended December 31, 2016 (calculated using the foreign currency exchange rates in effect during those periods) to non-GAAP revenue growth for the three month and year ended periods ended December 31, 2017 (as recalculated using 2016 foreign currency exchange rates in order to provide a constant currency comparison).



	Three Months Ended December 31, 2017							Three Months Ended December 31, 2016								%		% Change Adjusted
	GAAP		Adjustments⁴			Non-GAAP		GAAP		Adjustments⁴			Non-GAAP			Change		Revenue
Revenues
Injection Molding	$	50,245	$	-		$	50,245	$	41,598	$	(485	)	$	41,113		20.8	%	22.2	%
CNC Machining		30,421		(1,657	)		28,764	$	20,897		-			20,897		45.6	%	37.6	%
3D Printing		11,268		-			11,268		9,788		-			9,788		15.1	%	15.1	%
Sheet Metal		1,767		(1,767	)		0		-		-			-		*		*
Other		477		(155	)		322		70		-			70		*		*
Total Revenue	$	94,178	$	(3,579	)	$	90,599	$	72,353	$	(485	)	$	71,868		30.2	%	26.1	%

*Percentage change not meaningful.


	Year Ended							Year Ended										% Change
	December 31, 2017							December 31, 2016								%		Adjusted
	GAAP		Adjustments⁴			Non-GAAP		GAAP		Adjustments⁴			Non-GAAP			Change		Revenue
Revenues
Injection Molding	$	194,432	$	(550	)	$	193,882	$	175,974	$	(2,904	)	$	173,070		10.5	%	12.0	%
CNC Machining		103,739		(1,657	)		102,082		81,407		-			81,407		27.4	%	25.4	%
3D Printing		43,329		-			43,329		37,847		(242	)		37,605		14.5	%	15.2	%
Sheet Metal		1,767		(1,767	)		0		-		-			-		*		*
Other		1,223		(155	)		1,068		2,827		(1,784	)		1,043		*		*
Total Revenue	$	344,490	$	(4,129	)	$	340,361	$	298,055	$	(4,930	)	$	293,125		15.6	%	16.1	%

*Percentage change not meaningful.

⁴ Revenue growth for the three month and year periods ended December 31, 2017 and 2016 has been recalculated to exclude revenue earned from the acquisition of Rapid and two discontinued manufacturing processes, Metal Injection Molding (MIM) and Magnesium Thixomolding (Thixo), discontinued non-core resin resale business and unprofitable Alphaform 3D Printing contracts.


Proto Labs, Inc.
Revenue by Geography
(In thousands)
(Unaudited)

	Three Months Ended				Year Ended
	December 31,				December 31,
	2017		2016		2017		2016
Revenue:
United States	$	72,067	$	54,566	$	263,086	$	223,930
Europe		18,930		14,847		70,154		63,365
Japan		3,181		2,940		11,250		10,760
Total Revenue	$	94,178	$	72,353	$	344,490	$	298,055

Proto Labs, Inc.

Product Developer Information

(Unaudited)

Three Months Ended

Year Ended

December 31,

2017

2016

2017

2016

Unique product developers and engineers served

16,985

14,046

37,267

31,457

Note: the information above includes unique product developers and engineers who purchased our 3D Printed products in the United States and Europe through our web-based customer interface. The information does not include 3D Printing, Injection Molding and Sheet Metal customers resulting from the Alphaform and RAPID acquisitions who do not utilize our web-based customer interface.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180208005245/en/

PRLBProto Labs Inc

$62.08-%

Overview

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.